Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-12

Clinical Trial Update: Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial [NA]

View source ↗

Summary

A multi-center clinical trial evaluating reverse-engineering of exclusive enteral nutrition (RE-EEN) in Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seattle Children's Hospital | Conditions: Crohn Disease | NA | Status: RECRUITING